Studies Conducted at National Institute of Allergy and Infectious Diseases (NIAID) on Remdesivir Recently Reported (Temporal Improvements In Covid-19 Outcomes for Hospitalized Adults: a Post Hoc Observational Study of Remdesivir Group ...)

Press/Media

Period2 Mar 2023

Media coverage

1

Media coverage

  • TitleStudies Conducted at National Institute of Allergy and Infectious Diseases (NIAID) on Remdesivir Recently Reported (Temporal Improvements In Covid-19 Outcomes for Hospitalized Adults: a Post Hoc Observational Study of Remdesivir Group ...)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date2/03/23
    PersonsAnuradha Ganesan, Tahaniyat Lalani